Immune phenotypes in lung cancer patients with COPD: potential implications for immunotherapy

J Thorac Dis. 2018 Jul;10(Suppl 18):S2186-S2189. doi: 10.21037/jtd.2018.06.143.

Roberto Chalela^{1

2}, Joaquim Gea^{1

2}, Esther Barreiro^{1

2}

¹ Pulmonology Department-Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, IMIM-Hospital del Mar, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF), Barcelona Biomedical Research Park (PRBB), Barcelona, Spain.
² Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Monforte de Lemos, Madrid, Spain.

No abstract available

Publication types